Results for tag: "Radium 223 Dichloride"

Radium 223 Dichloride is an oncology drug used to treat prostate cancer that has spread to the bones. It is a radioactive form of the element radium, and is administered intravenously. The drug works by targeting and killing cancer cells in the bones, while sparing healthy cells. It is used to reduce pain and improve quality of life in patients with advanced prostate cancer. Radium 223 Dichloride is approved by the US Food and Drug Administration (FDA) and is available in many countries around the world. It is typically used in combination with other treatments such as hormone therapy and chemotherapy. The market for Radium 223 Dichloride is growing as more patients are being diagnosed with prostate cancer. The drug is becoming increasingly popular due to its effectiveness in treating advanced prostate cancer. Some companies in the Radium 223 Dichloride market include Bayer, Novartis, and Astellas Pharma. Show Less Read more